Pulmonary Critical Care Associates of Baltimore Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2002
NCT00122018
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Alternative names

Linda F. Barr, M.D.